These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9343169)
1. Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus type 31 on stable and transient viral replication. Klumpp DJ; Stubenrauch F; Laimins LA J Virol; 1997 Nov; 71(11):8186-94. PubMed ID: 9343169 [TBL] [Abstract][Full Text] [Related]
2. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. Stubenrauch F; Hummel M; Iftner T; Laimins LA J Virol; 2000 Feb; 74(3):1178-86. PubMed ID: 10627528 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Thomas JT; Hubert WG; Ruesch MN; Laimins LA Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8449-54. PubMed ID: 10411895 [TBL] [Abstract][Full Text] [Related]
4. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. Frattini MG; Lim HB; Doorbar J; Laimins LA J Virol; 1997 Sep; 71(9):7068-72. PubMed ID: 9261437 [TBL] [Abstract][Full Text] [Related]
5. Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. Wilson R; Fehrmann F; Laimins LA J Virol; 2005 Jun; 79(11):6732-40. PubMed ID: 15890911 [TBL] [Abstract][Full Text] [Related]
6. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. Stubenrauch F; Lim HB; Laimins LA J Virol; 1998 Feb; 72(2):1071-7. PubMed ID: 9445001 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. Hubert WG; Laimins LA J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404 [TBL] [Abstract][Full Text] [Related]
8. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Frattini MG; Lim HB; Laimins LA Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3062-7. PubMed ID: 8610168 [TBL] [Abstract][Full Text] [Related]
9. Characterization of cDNAs of spliced HPV-11 E2 mRNA and other HPV mRNAs recovered via retrovirus-mediated gene transfer. Rotenberg MO; Chiang CM; Ho ML; Broker TR; Chow LT Virology; 1989 Oct; 172(2):468-77. PubMed ID: 2552658 [TBL] [Abstract][Full Text] [Related]
10. A novel splice donor site at nt 1534 is required for long-term maintenance of HPV31 genomes. Poppelreuther S; Iftner T; Stubenrauch F Virology; 2008 Jan; 370(1):93-101. PubMed ID: 17904182 [TBL] [Abstract][Full Text] [Related]
11. Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. Sherman L; Alloul N; Golan I; Durst M; Baram A Int J Cancer; 1992 Feb; 50(3):356-64. PubMed ID: 1310488 [TBL] [Abstract][Full Text] [Related]
12. Alterations in physical state and expression of human papillomavirus type 18 DNA following crisis and establishment of immortalized ectocervical cells. Yokoyama M; Nakao Y; Yang X; Sun Q; Tsutsumi K; Pater A; Pater MM Virus Res; 1995 Jul; 37(2):139-51. PubMed ID: 7483827 [TBL] [Abstract][Full Text] [Related]
13. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. Hummel M; Hudson JB; Laimins LA J Virol; 1992 Oct; 66(10):6070-80. PubMed ID: 1326657 [TBL] [Abstract][Full Text] [Related]
14. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes. Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800 [TBL] [Abstract][Full Text] [Related]
15. Persistence of an Oncogenic Papillomavirus Genome Requires Van Doorslaer K; Chen D; Chapman S; Khan J; McBride AA mBio; 2017 Nov; 8(6):. PubMed ID: 29162712 [TBL] [Abstract][Full Text] [Related]
16. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. Rotenberg MO; Chow LT; Broker TR Virology; 1989 Oct; 172(2):489-97. PubMed ID: 2552659 [TBL] [Abstract][Full Text] [Related]
17. A major transcript of human papillomavirus type 16 in transformed NIH 3T3 cells contains polycistronic mRNA encoding E7, E5, and E1--E4 fusion gene. Taniguchi A; Yasumoto S Virus Genes; 1990 Feb; 3(3):221-33. PubMed ID: 2161158 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. Fehrmann F; Klumpp DJ; Laimins LA J Virol; 2003 Mar; 77(5):2819-31. PubMed ID: 12584305 [TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors. Lusky M; Botchan MR J Virol; 1985 Mar; 53(3):955-65. PubMed ID: 2983102 [TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. Park RB; Androphy EJ J Virol; 2002 Nov; 76(22):11359-64. PubMed ID: 12388696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]